A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus
about
Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future PerspectivesEmerging therapies for systemic lupus erythematosus--focus on targeting interferon-alphaGenetic risk factors in lupus nephritis and IgA nephropathy--no support of an overlap.Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays.Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.A research study of the association between maternal microchimerism and systemic lupus erythematosus in adults: a comparison between patients and healthy controls based on single-nucleotide polymorphism using quantitative real-time PCRInterferon regulatory factors: critical mediators of human lupus.Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis.Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-upThe pro-inflammatory signalling regulator Stat4 promotes vasculogenesis of great vessels derived from endothelial precursors.Potential role of IFNα in adult lupus.Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Altered neurotrophic factors' expression profiles in the nucleus of the solitary tract of spontaneously hypertensive rats.The Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus.IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis.Systemic lupus erythematosus: still a challenge for physicians.Platelet-Derived S100A8/A9 and Cardiovascular Disease in Systemic Lupus Erythematosus.Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus.Altered β2 -glycoprotein I expression on microparticles in the presence of antiphospholipid antibodies.Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE.A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locusCerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosusObstetric antiphospholipid syndrome
P2860
Q26774815-80B8DFC9-0B61-4E62-8691-46520C31CBC4Q28265144-7349D8D8-246F-42C1-B822-069AF6DF48EEQ30982765-765516A8-2F89-4898-9995-8D7B69AEF071Q33387473-A2C126EC-303F-4C90-AA00-67BB2E4F9639Q33404418-05589274-9A32-4B16-88BC-F9052182734CQ34240254-7C4FAB0C-E705-4A5B-913C-21EB43D8B226Q34990102-FD662ED6-351D-4E65-9D99-412D42CC5EEAQ35014051-06E524D1-9ECF-45CC-90D2-91EA364B3C1EQ35080952-3AD563F3-0F09-4A1E-AF1F-7DF7B39C6E82Q35645573-756BAC8B-BB1D-467D-8190-AFA64E9C9A2AQ37681889-66CD5269-EBDB-47A5-8F64-B6C6E1C850C5Q37730992-490CA412-9B88-4844-A251-8C2FA78CA561Q38162490-5835CFB0-36B7-4203-9FDC-8FA118125C72Q38826410-E6F0E0CA-F5EF-488E-8366-0C81C02A2DC1Q38842404-9B15E825-7950-40A4-91C2-BD126970D2D7Q38856073-8198847D-A95C-4EDF-8159-84C03CDDC522Q38866356-C244C5C6-4B4C-4CE4-AA09-B52162CC43AFQ38899360-7B6131AD-A5EF-4783-8473-FE66D64FDE0CQ43885994-E1984A5A-300C-4305-BA1E-69974D816C72Q45843374-23B72908-A7CF-4FEE-B3D5-A755A40E0088Q52589984-C089CC9F-D6CC-4675-B40A-8DBC6EE2C49BQ52668758-1405B2BA-1DFE-4CF5-8794-0E698C639723Q54983754-919F1DD3-29D3-4D52-B14F-EFDCA03DFF03Q56451740-F5E4198B-DDAF-4D72-B643-57F109416B2DQ58190179-7B078CC2-DE11-4ED3-BA96-FE0CC6AB7CB7Q58551653-FBF6C45E-A275-4C7E-A7DF-00E7D42E092A
P2860
A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A STAT4 risk allele is associa ...... n systemic lupus erythematosus
@ast
A STAT4 risk allele is associa ...... n systemic lupus erythematosus
@en
A STAT4 risk allele is associa ...... n systemic lupus erythematosus
@nl
type
label
A STAT4 risk allele is associa ...... n systemic lupus erythematosus
@ast
A STAT4 risk allele is associa ...... n systemic lupus erythematosus
@en
A STAT4 risk allele is associa ...... n systemic lupus erythematosus
@nl
prefLabel
A STAT4 risk allele is associa ...... n systemic lupus erythematosus
@ast
A STAT4 risk allele is associa ...... n systemic lupus erythematosus
@en
A STAT4 risk allele is associa ...... n systemic lupus erythematosus
@nl
P2093
P50
P356
P1476
A STAT4 risk allele is associa ...... n systemic lupus erythematosus
@en
P2093
Anders A Bengtsson
Andreas Jönsen
Dag Leonard
Gunnar Sturfelt
Gunnel Nordmark
Iva Gunnarsson
Johanna Gustafsson
Kerstin Elvin
Lars Rönnblom
Ulf Sundin
P304
P356
10.1136/ARD.2009.115535
P407
P50
P577
2010-05-01T00:00:00Z